Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-25-001047
Filing Date
2025-02-19
Accepted
2025-02-19 16:36:18
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3901
  Complete submission text file 0001950047-25-001047.txt   5459
Mailing Address C/O IDENIX PHARMACEUTICALS, INC. 60 HAMPSHIRE STREET CAMBRIDGE MA 02139
Business Address
Thomas-Graham Pamela (Reporting) CIK: 0001327431 (see all company filings)

Type: 144

Mailing Address 110 FIFTH AVENUE 4TH FLOOR NEW YORK NY 10011
Business Address 110 FIFTH AVENUE 4TH FLOOR NEW YORK NY 10011 212-913-9058
Compass, Inc. (Subject) CIK: 0001563190 (see all company filings)

EIN.: 300751604 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-40291 | Film No.: 25640836
SIC: 7371 Services-Computer Programming Services
(CF Office: 06 Technology)